Efficacy and safety of pirfenidone in the treatment of idiopathic pulmonary fibrosis patients: a systematic review and meta-analysis of randomised controlled trials
Objectives Idiopathic pulmonary fibrosis (IPF) has been defined as a distinctive type of chronic fibrotic disease, characterised by a progressive decline in lung function and a common histological pattern of interstitial pneumonia. To analyse the efficacy and safety of pirfenidone in the treatment o...
Saved in:
| Main Authors: | Wenjuan Wu, Guojun Zhang, Lingxiao Qiu, Jizhen Wu, Xueya Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-12-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/11/12/e050004.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real-World Practice Patterns for Prevention and Management of Potential Adverse Events with Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
by: Mark L. Wencel, et al.
Published: (2018-06-01) -
Effect and Safety of Mycophenolate Mofetil in Idiopathic Pulmonary Fibrosis
by: Argyris Tzouvelekis, et al.
Published: (2011-01-01) -
Pirfenidone Alleviates Choroidal Neovascular Fibrosis through TGF-β/Smad Signaling Pathway
by: Chuang Gao, et al.
Published: (2021-01-01) -
Vascular involvement in idiopathic pulmonary fibrosis
by: Michele Mondoni, et al.
Published: (2024-11-01) -
Molecular genetics of idiopathic pulmonary fibrosis
by: R. N. Mustafin
Published: (2022-06-01)